About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

6-week Safety and PD Study in Adults With NAFLD

NCT03256526·9 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

BMI at least 28 kg/m2
Type 2 diabetes and/or metabolic syndrome

You may not be if

Liver disease
Type 1 diabetes
Recent heart attack or stroke
Inability to have an MRI scan

The record

StatusCompleted

PhasePhase 2

Taking part53

StartedSep 2017

UpdatedApr 4, 2019

Conditions

Non-alcoholic Fatty Liver Disease

Where9

National Research Institute
Los Angeles, California, United States
Avail Clinical Research, LLC
DeLand, Florida, United States
Stand-Up MRI of Miami
Miami, Florida, United States

Clareo Health | 6-week Safety and PD Study in Adults With NAFLD